학술논문
1200TiP Phase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC)
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S1097-S1097
Subject
Language
ISSN
0923-7534